Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work
- Supplementary File 1:
PDF-Document (PDF, 737 KiB)
Iles, R.K.; Zmuidinaite, R.; Iles, J.K.; Carnell, G.; Sampson, A.; Heeney, J.L. Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work. Diagnostics 2020, 10, 746. https://doi.org/10.3390/diagnostics10100746
Iles RK, Zmuidinaite R, Iles JK, Carnell G, Sampson A, Heeney JL. Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work. Diagnostics. 2020; 10(10):746. https://doi.org/10.3390/diagnostics10100746
Chicago/Turabian StyleIles, Ray K., Raminta Zmuidinaite, Jason K. Iles, George Carnell, Alex Sampson, and Jonathan L. Heeney. 2020. "Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work" Diagnostics 10, no. 10: 746. https://doi.org/10.3390/diagnostics10100746